Cargando…
A novel role of HLA class I in the pathology of medulloblastoma
BACKGROUND: MHC class I expression by cancer cells enables specific antigen recognition by the immune system and protection of the host. However, in some cancer types MHC class I expression is associated with an unfavorable outcome. We explored the basis of MHC class I association with unfavorable p...
Autores principales: | Smith, Courtney, Santi, Mariarita, Rajan, Bhargavi, Rushing, Elisabeth J, Choi, Mi Rim, Rood, Brian R, Cornelison, Robert, MacDonald, Tobey J, Vukmanovic, Stanislav |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714836/ https://www.ncbi.nlm.nih.gov/pubmed/19594892 http://dx.doi.org/10.1186/1479-5876-7-59 |
Ejemplares similares
-
MDB-03. DFMO AS A TREATMENT STRATEGY IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2023) -
EMBR-12. TARGETING THE RNA-BINDING PROTEIN LIN28B IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2021) -
MEDB-63. Deciphering the role of LIN28B in Group 3 medulloblastoma
por: Shahab, Shubin, et al.
Publicado: (2022) -
Medulloblastoma and the DNA Damage Response
por: McSwain, Leon F., et al.
Publicado: (2022) -
Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma()
por: Siegel, Benjamin I, et al.
Publicado: (2019)